abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to biotechnology, specifically to a composition comprising a Factor VIII complex and one or more von Willebrand Factor peptides, where von Willebrand Factor peptides contain at least amino acids 764–1035 and 1691–1905 of SEQ ID NO: 1, but do not contain amino acids 2255–2645 of SEQ ID NO: 1, and can be used in medicine.EFFECT: said composition is used for effective treatment of haemophilia.12 cl, 14 dwg, 9 ex |